Nrf2 pathway activation and antioxidant defense
Sulforaphane is the most potent known natural activator of Nrf2 — the master transcription factor governing expression of over 200 cytoprotective genes including glutathione S-transferases, heme oxygenase-1, NQO1, and superoxide dismutase. Effects last 24–72 hours per dose due to sustained Nrf2 activation.
Cancer chemoprevention
Sulforaphane inhibits phase I carcinogen-activating enzymes while inducing phase II detoxification enzymes that neutralize carcinogens before DNA damage occurs. Epidemiological and clinical trial data supports inverse association between cruciferous vegetable consumption and risk of lung, breast, prostate, and colorectal cancers.
Autism spectrum disorder symptoms
A landmark Johns Hopkins double-blind RCT showed sulforaphane (50–150 μmol/day) significantly improved social interaction, aberrant behavior, and verbal communication in young men with moderate-to-severe ASD over 18 weeks — the largest effect size of any compound tested in ASD to date.
Cardiovascular and metabolic health
Sulforaphane reduces oxidized LDL, improves endothelial function via Nrf2-driven HO-1 expression, and significantly reduces fasting blood glucose and HbA1c in type 2 diabetic patients — effects demonstrated in a clinical trial published in Science Translational Medicine.
Detoxification and pollution protection
Sulforaphane accelerates urinary excretion of benzene, acrolein, and other airborne carcinogens by upregulating glutathione conjugation and mercapturic acid pathway enzymes. Clinical trial in China showed 61–69% increased excretion of benzene and acrolein in polluted urban environment.
Nrf2-Keap1 pathway activation
Sulforaphane modifies cysteine residues on Keap1 (the Nrf2 repressor protein), preventing Keap1-mediated Nrf2 ubiquitination and proteasomal degradation. Free Nrf2 translocates to the nucleus and binds antioxidant response elements (AREs), inducing transcription of over 200 cytoprotective genes simultaneously.
Histone deacetylase (HDAC) inhibition
Sulforaphane inhibits class I and II histone deacetylases, maintaining chromatin in an open, transcription-accessible state at tumor suppressor gene loci. This epigenetic mechanism contributes to its cancer preventive effects independently of Nrf2 activation.
Phase II detoxification enzyme induction
Sulforaphane induces glutathione S-transferases (GSTs), NQO1 (NAD(P)H quinone oxidoreductase), and epoxide hydrolases that convert reactive carcinogen metabolites to water-soluble mercapturic acid conjugates for urinary excretion — providing systemic chemoprotection.
Randomized, double-blind, placebo-controlled trial of sulforaphane (50–150 μmol/day from broccoli sprout extract) in 29 young men with moderate-to-severe ASD for 18 weeks.
29 young men with ASD aged 13–27. 18-week intervention.
Sulforaphane significantly improved social responsiveness (SRS: -34%), aberrant behavior (ABC: -17%), and social communication vs. placebo. Effects reversed upon discontinuation. No serious adverse events. Largest effect size of any compound in ASD clinical trials.
Clinical trial examining sulforaphane (concentrated broccoli sprout extract delivering ~150 μmol sulforaphane/day) in 97 patients with type 2 diabetes for 12 weeks.
97 T2DM patients. 12-week intervention.
Sulforaphane significantly reduced fasting blood glucose (significant in obese dysregulated subgroup) and HbA1c vs. placebo. Mechanism confirmed as NRF2-mediated suppression of glucose production enzymes in liver. Published in Science Translational Medicine.
Randomized, placebo-controlled trial of broccoli sprout beverage (delivering ~26–40 μmol sulforaphane/day) in 291 healthy adults in polluted Jiangsu province, China for 12 weeks.
291 healthy adults in heavily polluted region. 12-week intervention.
Broccoli sprout drink significantly increased urinary excretion of benzene (61%), acrolein (23%), and crotonaldehyde (23%) vs. placebo — demonstrating real-world protection against air pollution carcinogens.